Exagen Market Cap

Exagen has a market cap or net worth of $163.17 million as of December 5, 2025. Its market cap has increased by 208.39% in one year.

Market Cap

163.17M

Enterprise Value

155.69M

1-Year Change

208.39%

Ranking

#3938

Market Cap Chart

Since September 19, 2019, Exagen's market cap has increased from $63.11M to $163.17M, an increase of 158.57%. That is a compound annual growth rate of 16.52%.

Market Cap History

Date	Market Cap	% Change
Dec 4, 2025	169.75M	134.74%
Dec 31, 2024	72.31M	113.18%
Dec 29, 2023	33.92M	-13.39%
Dec 30, 2022	39.17M	-79.17%
Dec 31, 2021	187.99M	12.56%
Dec 31, 2020	167.01M	-47.65%
Dec 31, 2019	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	905.87B
Johnson & Johnson	487.45B
AbbVie	403.78B
UnitedHealth Group	302.89B
AstraZeneca	283.29B
Novartis AG	257.47B
Merck & Co.	252.17B
Abbott Laboratories	216.16B

Market Cap Rankings